Medicofarma Biotech SA (WSE:MDB)

Medicofarma Biotech Statistics

Total Valuation

WSE:MDB has a market cap or net worth of PLN 32.63 million. The enterprise value is 36.34 million.

Market Cap	32.63M
Enterprise Value	36.34M

Important Dates

The last earnings date was Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

WSE:MDB has 67.98 million shares outstanding.

Current Share Class	67.98M
Shares Outstanding	67.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	272.14
PB Ratio	5.74
P/TBV Ratio	5.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.29
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.25, with a Debt / Equity ratio of 0.65.

Current Ratio	1.25
Quick Ratio	1.25
Debt / Equity	0.65
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.75

Financial Efficiency

Return on equity (ROE) is -35.52% and return on invested capital (ROIC) is -19.51%.

Return on Equity (ROE)	-35.52%
Return on Assets (ROA)	-7.35%
Return on Invested Capital (ROIC)	-19.51%
Return on Capital Employed (ROCE)	-16.82%
Weighted Average Cost of Capital (WACC)	10.42%
Revenue Per Employee	8,564
Profits Per Employee	-159,323
Employee Count	6
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.62% in the last 52 weeks. The beta is 1.06, so WSE:MDB's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	+84.62%
50-Day Moving Average	0.48
200-Day Moving Average	0.47
Relative Strength Index (RSI)	50.50
Average Volume (20 Days)	39,246

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:MDB had revenue of PLN 119,900 and -2.23 million in losses. Loss per share was -0.03.

Revenue	119,900
Gross Profit	-1.10M
Operating Income	-1.70M
Pretax Income	-2.23M
Net Income	-2.23M
EBITDA	-208,222
EBIT	-1.70M
Loss Per Share	-0.03

Balance Sheet

The company has 1,742 in cash and 3.71 million in debt, with a net cash position of -3.71 million or -0.05 per share.

Cash & Cash Equivalents	1,742
Total Debt	3.71M
Net Cash	-3.71M
Net Cash Per Share	-0.05
Equity (Book Value)	5.68M
Book Value Per Share	0.08
Working Capital	1.02M

Cash Flow

Operating Cash Flow	-983,559
Capital Expenditures	n/a
Depreciation & Amortization	1.49M
Net Borrowing	979,060
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-1,418.73%
Pretax Margin	-1,860.32%
Profit Margin	n/a
EBITDA Margin	-173.66%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WSE:MDB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.84%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 8, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

WSE:MDB has an Altman Z-Score of 0.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.59
Piotroski F-Score	2